4.3 Non-Infectious Dermatoses, Neoplasms & Contraindications

4.3 Non-Infectious Dermatoses, Neoplasms & Contraindications

Core Examination Principle: Non-infectious dermatoses, pigmentary anomalies, and cutaneous neoplasms represent chronic physiological, immunological, genetic, or neoplastic alterations rather than transmissible microbial infections. While these conditions cannot be passed to the practitioner or other clients, they frequently impair the skin's barrier integrity, vascular stability, and cellular architecture. Practitioners must recognize their clinical hallmarks, modify treatment parameters to prevent disease exacerbation, and maintain vigilant oncological screening using the ABCDE criteria for immediate medical referral.

---

1. Non-Infectious Inflammatory Dermatoses

Inflammatory skin disorders are driven by immune dysregulation, genetic barrier defects, neurovascular hyperreactivity, or exogenous chemical irritants.

Inflammatory Dermatoses Classification:
├── Barrier & Hypersensitivity Eczemas
│   ├── Atopic Dermatitis (filaggrin deficiency; flexural lichenification)
│   ├── Allergic Contact Dermatitis (Type IV delayed cell-mediated immunity)
│   └── Irritant Contact Dermatitis (direct non-immune chemical barrier disruption)
├── Autoimmune Hyperproliferative Disorders
│   └── Psoriasis (T-cell mediated; 3-5 day turnover; silvery plaques; Auspitz sign)
└── Pilosebaceous & Facial Vascular Disorders
    ├── Acne Vulgaris (comedones, papules, pustules, cysts; Grades I-IV)
    └── Rosacea (vascular reactivity; flushing, telangiectasia; NO COMEDONES)

Atopic Dermatitis (Eczema)

• Pathophysiology: A chronic, pruritic inflammatory skin disorder resulting from a genetic defect in the epidermal barrier—most notably loss-of-function mutations in the FLG gene encoding filaggrin. Filaggrin deficiency disrupts keratohyalin aggregation, resulting in impaired lamellar lipid extrusion, elevated transepidermal water loss (TEWL), and deep penetration of environmental allergens. This activates a Th2-skewed immune response, causing intense pruritus ("the itch that rashes").
• Clinical Manifestations:
  • Acute Phase: Intensely pruritic, ill-defined erythematous macules, papules, and microvesicles that weep serous fluid and crust.
  • Chronic Phase: Dry, xerotic skin accompanied by marked lichenification (thickened, leathery skin with exaggerated creases) resulting from constant mechanical scratching and rubbing.
  • Distribution: Predilection for flexural surfaces (antecubital and popliteal fossae, anterior neck, wrists, and eyelids).
• Therapy Considerations: Local Contraindication to active weeping or cracked lesions. Avoid harsh exfoliants, heating blankets, alcohol-based toners, and deep friction massage. Unbroken, xerotic skin benefits from barrier-restorative emollients rich in ceramides and fatty acids.

Contact Dermatitis: Allergic vs. Irritant

Contact dermatitis is an acute or chronic cutaneous inflammatory reaction triggered by external substances coming into direct physical contact with the skin:

Psoriasis: Autoimmune Hyperproliferation

• Pathophysiology: A chronic, systemic autoimmune disease mediated by hyperactive helper T cells (Th17 and Th1) that secrete pro-inflammatory cytokines, including interleukin-17 (IL-17), interleukin-23 (IL-23), and tumor necrosis factor-alpha (TNF-alpha). This inflammatory signaling drives uncontrolled mitotic proliferation of basal keratinocytes, drastically compressing the epidermal turnover cycle from the normal 28–40 days down to just 3 to 5 days.
• Consequences of Rapid Transit: Keratinocytes do not have adequate time to undergo terminal differentiation; they reach the skin surface still retaining their cell nuclei (parakeratosis) and cannot synthesize mature intercellular lipids, piling up into dense, adherent silvery scales.
• Clinical Signs: Sharply circumscribed, elevated, salmon-pink or dull erythematous plaques capped with thick, coarse, micaceous silvery-white scales. Common on extensor surfaces (elbows, knees, scalp, lumbosacral spine, and umbilicus).
• Pathognomonic Psoriatic Phenomena:
  • Auspitz Sign: The appearance of multiple pinpoint bleeding spots when the silvery psoriatic scales are gently scraped away. This occurs because the suprapapillary epidermal plates are severely thinned, exposing engorged, dilated, tortuous capillary loops within elongated dermal papillae directly beneath the scales.
  • Koebner Phenomenon (Isomorphic Response): The induction of new psoriatic plaques on previously unaffected, healthy skin following local mechanical trauma, scratching, sunburn, chemical peels, or friction.
• Therapy Considerations: Local Contraindication to active psoriatic plaques. Therapists must never vigorously scrub, exfoliate, or use microdermabrasion over psoriatic lesions or healthy skin in psoriatic clients, as mechanical trauma directly precipitates the Koebner phenomenon.

Acne Vulgaris: Pilosebaceous Pathology

Acne vulgaris is a multifactorial chronic inflammatory disorder affecting the pilosebaceous unit (hair follicle and attached sebaceous gland), governed by four interconnected pathogenic factors:

1. Retention Hyperkeratinisation: Keratinocytes in the follicular infundibulum become abnormally cohesive, failing to desquamate and forming a microscopic keratin plug (microcomedo).
2. Androgen-Driven Sebum Hypersecretion: Circulating androgens stimulate sebaceous glands to enlarge and oversecrete thick, lipid-rich sebum.
3. Microbial Proliferation: Trapped sebum creates an anaerobic, lipid-dense environment that fuels the uncontrolled proliferation of Cutibacterium acnes (C. acnes, formerly Propionibacterium acnes).
4. Inflammation & Follicular Rupture: C. acnes secretes lipases that break sebum triglycerides into free fatty acids, attracting neutrophils and triggering the release of pro-inflammatory cytokines. The follicular wall ruptures, spilling keratin, bacteria, and lipids into the vascular dermis.

Acne Lesions Morphology:
├── Non-Inflammatory Lesions
│   ├── Closed Comedones ("Whiteheads" - small closed follicular papules)
│   └── Open Comedones ("Blackheads" - dilated orifice with oxidized melanin/sebum)
└── Inflammatory Lesions
    ├── Inflammatory Papules (small, red, tender solid elevations)
    ├── Pustules (superficial purulent exudate around follicle)
    └── Nodules & Cysts (deep, painful, indurated, fluctuant dermal destruction)

Clinical Grading of Acne Vulgaris (Grades I to IV)

• Grade I (Mild): Dominated by non-inflammatory comedones (open and closed) with few scattered, minor superficial papules; no scarring.
• Grade II (Moderate): Frequent open and closed comedones accompanied by multiple prominent inflammatory papules and pustules; localized erythema.
• Grade III (Moderately Severe): Numerous papules, widespread superficial and deep pustules, and occasional painful inflammatory nodules; prominent erythema and early scarring.
• Grade IV (Severe / Acne Conglobata): Highly inflammatory, widespread destructive lesions featuring confluent painful nodules, deep fluctuating cysts, interconnecting sinus tracts, purulent drainage, and severe permanent ice-pick and keloidal scarring.
• Therapy Adaptations: Grade I and mild Grade II acne are suitable for professional aesthetic treatments (gentle non-comedogenic hydration, salicylic acid peels, manual extraction of open comedones using aseptic lancets). Grades III and IV represent a Total Contraindication to mechanical stimulation, aggressive extractions, and facial massage, requiring formal medical referral for systemic dermatological therapy (oral retinoids/antibiotics).

Rosacea: Chronic Facial Vascular & Inflammatory Disorder

• Pathophysiology: A chronic facial vascular disorder characterized by capillary hyperreactivity, neurogenic inflammation, and innate immune dysregulation (overproduction of cathelicidin antimicrobial peptides and kallikrein 5 proteases).
• Diagnostic Distinction from Acne: Rosacea NEVER exhibits comedones. The presence of open or closed comedones excludes a pure diagnosis of rosacea.
• Four Clinical Subtypes:
  1. Erythematotelangiectatic Rosacea: Persistent central facial erythema, flushing, and visible spider veins (telangiectasias) across the nose, cheeks, and forehead.
  2. Papulopustular Rosacea: Central facial erythema accompanied by crops of dome-shaped inflammatory papules and pustules (often misdiagnosed as adult acne).
  3. Phymatous Rosacea: Progressive dermal connective tissue hypertrophy and sebaceous gland hyperplasia leading to irregular, bulbous, nodular enlargement—most commonly affecting the nose (rhinophyma).
  4. Ocular Rosacea: Blepharitis, conjunctival injection, grittiness, burning, and dryness of the eyes.
• Trigger Factors: Thermal extremes, hot beverages, spicy foods (capsaicin), alcohol consumption, ultraviolet radiation, and emotional stress.
• Therapy Protocol: Strictly avoid steam, hot compresses, stimulating electrical currents, microdermabrasion, and vigorous effleurage; use cool compresses, gentle lymphatic drainage, and soothing anti-inflammatory topicals.

---

2. Cutaneous Pigmentary Disorders

Pigmentary disorders result from quantitative alterations in melanocyte function or localized melanocyte proliferation:

Pigmentary Anomalies:
├── Hypopigmentation / Depigmentation
│   ├── Vitiligo (autoimmune destruction of melanocytes; chalky-white patches)
│   └── Albinism (autosomal recessive tyrosinase enzyme absence; complete melanin lack)
└── Hyperpigmentation
    ├── Melasma / Chloasma ("mask of pregnancy"; hormonal/UV centrofacial patches)
    ├── Ephelides (freckles; normal melanocyte count, increased melanin synthesis)
    └── Lentigines (age/liver spots; localized proliferation of basal melanocytes)

Hypopigmentation & Depigmentation

• Vitiligo: An acquired autoimmune dermatosis characterized by the selective destruction of epidermal melanocytes by autoreactive cytotoxic T lymphocytes. Clinically manifests as sharply demarcated, amelanotic, milky-white macules and patches, frequently surrounded by a hyperpigmented rim. Predilection for periorificial skin (lips, eyes), distal extremities (hands, fingers), and skin folds. Clients have no photoprotection in affected zones and require broad-spectrum high-SPF sunscreen to prevent severe sunburn.
• Albinism (Oculocutaneous Albinism): A group of rare, inherited autosomal recessive genetic disorders characterized by a congenital absence or severe mutation of the copper-dependent enzyme tyrosinase. Without tyrosinase, melanocytes cannot metabolize tyrosine into melanin. Clinically marked by a complete absence of melanin pigment in the skin, hair, and eyes (pinkish-white skin, white hair, translucent irises, photophobia, nystagmus). Individuals have zero endogenous UV protection and carry an extreme risk of developing cutaneous malignancies.

Hyperpigmentation: Hormonal, Genetic & Actinic

• Melasma (Chloasma / "Mask of Pregnancy"): An acquired hypermelanosis of sun-exposed skin presenting as symmetric, irregular, blotchy brownish macules and patches across the centrofacial zone (forehead, cheeks, upper lip, chin). Driven by high levels of circulating estrogen and progesterone (pregnancy, oral contraceptives, hormone replacement therapy) interacting with ultraviolet radiation (UVR) and visible light. Melanocytes become hyperactive without increasing in absolute cell number.
• Ephelides (Freckles): Small (1–3 mm), flat, sharply circumscribed tan-to-reddish-brown macules appearing on sun-exposed skin of fair-skinned individuals. Melanocyte numbers are completely normal; ephelides develop because melanocytes produce increased amounts of eumelanin and pheomelanin upon UV exposure. They darken during summer sun exposure and fade substantially during winter months.
• Lentigines (Solar Lentigines / "Age Spots" / "Liver Spots"): Benign, circumscribed, pigmented macules resulting from an actual increase in the absolute number of basal melanocytes (melanocyte hyperplasia) induced by chronic, cumulative ultraviolet radiation. Unlike freckles, solar lentigines do not fade during winter months and are permanent unless treated with targeted cryotherapy, laser ablation, or chemical peeling.

---

3. Cutaneous Neoplasms: Benign Lesions & Malignant Oncology

Neoplasms are abnormal masses of tissue resulting from autonomous cellular proliferation:

Cutaneous Neoplasms Classification:
├── Benign Cutaneous Lesions
│   ├── Seborrheic Keratosis (brown "stuck-on" warty plaque in mature adults)
│   ├── Skin Tags / Acrochordons (soft pedunculated fibrovascular outgrowths)
│   ├── Cherry Angiomas (bright red vascular papules of dilated capillaries)
│   └── Dermatofibromas (firm button-like dermal nodules with dimple sign)
└── Malignant Cutaneous Neoplasms (Skin Cancers)
    ├── Basal Cell Carcinoma (BCC: 75-80%; stratum basale; pearly rolled border)
    ├── Squamous Cell Carcinoma (SCC: ~20%; stratum spinosum; indurated scaly ulcer)
    └── Malignant Melanoma (most lethal; transformed melanocytes; ABCDE criteria)

Benign Cutaneous Lesions

• Seborrheic Keratosis: The most common benign cutaneous tumor in adults over 40. Presents as a sharply demarcated, round or oval, brownish-black, greasy or warty plaque that exhibits a distinct "stuck-on" appearance (as if a drop of melted candle wax or dry oatmeal was stuck to the skin). They contain horn pseudocysts and have zero malignant potential. Local contraindication to aggressive mechanical scrubbing.
• Skin Tags (Acrochordons): Small, soft, flesh-colored or hyperpigmented, pedunculated (stalked) outgrowths of loose fibrovascular tissue occurring in areas of friction (neck, axillae, inframammary folds, groin). Completely benign, but require gentle handling to prevent snagging and tearing.
• Cherry Angiomas (Campbell de Morgan Spots): Common benign vascular proliferations composed of clusters of dilated superficial capillaries, presenting as bright ruby-red, dome-shaped papules; benign with no malignant potential.
• Dermatofibromas: Firm, solitary, button-like dermal nodules (0.5–1 cm) commonly located on the lower legs, representing benign fibrous histiocytomas. Diagnostic sign: the "dimple sign" (pinching the lesion laterally causes it to dimple inward beneath the skin surface).

Malignant Neoplasms (Skin Cancers)

Skin cancers represent the most common malignancies in humans, dividing into non-melanoma skin cancers (BCC and SCC) and malignant melanoma:

The Clinical ABCDE Screening Rule for Malignant Melanoma

Every professional aesthetician and bodywork therapist must memorize and routinely apply the clinical ABCDE dermatological screening criteria during visual cutaneous examinations:

• A - Asymmetry: If the lesion is bisected with an imaginary line through the center, the two halves do not match in shape, elevation, or outline.
• B - Border Irregularity: The margins of the lesion are ragged, scalloped, notched, blurred, or poorly circumscribed, fading indistinctly into surrounding skin.
• C - Color Variegation: The pigmentation is non-uniform, displaying multiple conflicting shades and hues—including dark brown, pitch black, slate blue, reddish-pink, white (regression), or gray.
• D - Diameter: The diameter of the lesion is greater than 6 millimeters (>6 mm), approximately the width of a standard pencil eraser (although early melanomas can be smaller).
• E - Evolving: The most critical diagnostic criterion. Any observable change in a lesion's size, shape, elevation, color, surface texture, or the new onset of symptoms such as persistent pruritus, tenderness, ulceration, or spontaneous bleeding.

---

4. Professional Scope of Practice & Referral Protocol

Aesthetic and body therapists are strictly non-medical practitioners. Under professional licensing guidelines and health regulations:

• Therapists Must Never Diagnose: The therapist must never state to a client that a lesion is a "basal cell carcinoma" or reassure them that a changing pigmented nevus is "just a benign mole."
• Immediate Referral Protocol: If any lesion displays suspicious ABCDE characteristics, persistent ulceration that fails to heal after 3 weeks, or irregular induration, the therapist must:
  1. Refuse any local treatment, chemical application, or friction over the area.
  2. Tactfully inform the client: "I notice an unusual spot on your skin that requires examination by a doctor. As a therapist, I cannot evaluate it, and I strongly recommend scheduling an appointment with your GP or dermatologist for a professional assessment."
  3. Document the neutral observation on the client's consultation card ("pigmented lesion with irregular borders on right shoulder noted; medical referral advised; client signature obtained").

Exact Recognition Terms in the Unit Specification

The named taught content also includes several brief recognition terms that are easy to miss in a broad pathology discussion:

These conditions do not all require the same response. Contagious infection, suspicious change, acute inflammation, or broken skin requires postponement or medical referral; a stable benign variation may require only local modification. A Level 3 therapist recognizes and refers rather than diagnosing.